United Health Care stock price posted a sharp rise to $532.60 Monday afternoon as long-term yields fell, triggering sector-wide buying. Fund managers cite stable cash flows and dividend reliability as reasons to overweight healthcare in portfolios. During the last three months, 5 analysts shared their evaluations of Sabra Health Care REIT (NASDAQ: SBRA ), revealing diverse outlooks from bullish to bearish. On the bright side, the companyâs 13% revenue growth in Q2 shows strong results across UnitedHealthcare and Optum, the companyâs health services arm. Its steady cash flow gives it room to invest and handle costs better. Specifically, Optum generated $67.2 billion in Q2 revenue, up 6.8% from a year ago. The company has also made governance changes that could help improve decision-making. According to the tool, these factors support the stockâs strong financial base and long-term outlook. United Health Care stock price was up 1.1% to $533.35 by Monday close amid rumors of upcoming acquisitions in regional healthcare networks. Speculation on vertical integration continues to drive interest from hedge funds.
